---
document_datetime: 2023-09-21 20:02:21
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cabometyx-epar-all-authorised-presentations_en.pdf
document_name: cabometyx-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6899202
conversion_datetime: 2025-12-20 17:15:59.708319
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number                                     | (Invented) name               | Strength          | Pharmaceutical Form                                      | Route of Administration    | Immediate Packaging                       | Pack size                        |
|----------------------------------------------------|-------------------------------|-------------------|----------------------------------------------------------|----------------------------|-------------------------------------------|----------------------------------|
| EU/1/16/1136/002 EU/1/16/1136/004 EU/1/16/1136/006 | CABOMETYX CABOMETYX CABOMETYX | 20 mg 40 mg 60 mg | Film-coated tablet Film-coated tablet Film-coated tablet | Oral use Oral use Oral use | bottle (HDPE) bottle (HDPE) bottle (HDPE) | 30 tablets 30 tablets 30 tablets |